CellaVision AB
STO:CEVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
CellaVision AB
EPS (Diluted)
CellaVision AB
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CellaVision AB
STO:CEVI
|
EPS (Diluted)
kr6
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
EPS (Diluted)
kr0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
EPS (Diluted)
kr1
|
CAGR 3-Years
-29%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Getinge AB
STO:GETI B
|
EPS (Diluted)
kr8
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
EPS (Diluted)
kr1
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
EPS (Diluted)
kr6
|
CAGR 3-Years
4%
|
CAGR 5-Years
29%
|
CAGR 10-Years
11%
|
|
CellaVision AB
Glance View
CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
See Also
What is CellaVision AB's EPS (Diluted)?
EPS (Diluted)
6.4
SEK
Based on the financial report for Dec 31, 2025, CellaVision AB's EPS (Diluted) amounts to 6.4 SEK.
What is CellaVision AB's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
11%
Over the last year, the EPS (Diluted) growth was 9%. The average annual EPS (Diluted) growth rates for CellaVision AB have been 9% over the past three years , 11% over the past five years , and 11% over the past ten years .
